{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:03:47Z","timestamp":1791936227517,"version":"4.3.4"},"reference-count":32,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"\n Background & objectives:<\/jats:title>\n Studies have shown that insulin resistance and hyperinsulinaemia play a major role in the pathogenesis of polycystic ovary syndrome (PCOS). Therefore, the use of insulin sensitizing drugs in the treatment of PCOS has attracted the attention of medicine and researchers. The aim of this study was to investigate the effects of sitaformin (sitagliptin\/metformin) and metformin on the quality of oocyte and embryo in classic PCOS patients undergoing intracytoplasmic sperm injection (ICSI).<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Sixty patients of PCOS (25-35 yr) were randomly allocated into three groups (n=20, each group): a metformin-treated group (administered metformin 500 mg twice daily), a sitaformin-treated group (administered sitaformin 50\/500 mg twice daily) and a placebo group. Participants in all the groups received the drug two months prior to the start of the ovulation cycle and treatment continued until the day of the oocyte aspiration.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Serum insulin and total testosterone levels decreaseed significantly after treatment in both the treatment groups as compared to the placebo (P<\/jats:italic><0.05). A significant decrease in the number of immature oocytes [MI + germinal vesicle (GV) stage] was observed in metformin and sitaformin groups as compared to the placebo. In addition, sitaformin group when compared to the metformin group showed a significant decrease in the number of immature oocytes (P<\/jats:italic><0.05). The number of mature and normal MII oocytes increased significantly in both the treatment groups compared to the placebo group (P<\/jats:italic><0.05). The number of mature and normal oocytes increased in sitaformin group in comparison to the metformin group, but the difference was not significant. There was a significant increase in the number of grade I embryos, fertilization and cleavage rates in the sitaformin group compared to the other groups (P<\/jats:italic><0.05).<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n This is the first study to compare the impact of sitaformin with metformin on oocyte and embryo quality in women with PCOS undergoing a gonadotropin-releasing hormone (GnRH) antagonist cycle. In conclusion, sitaformin can be more effective in decreasing immature oocytes and increasing the quality of embryos than the use of metformin.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_2139_20","type":"journal-article","created":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T10:04:47Z","timestamp":1680429887000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Comparative evaluation of metformin & sitaformin in classic PCOS patients undergoing intracytoplasmic sperm injection"],"prefix":"10.25259","volume":"157","author":[{"given":"Shahrzad Zadeh","family":"Modarres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delbar","family":"Daneshjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek Soleimani","family":"Mehranjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad Ali","family":"Shariatzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-10-20241212","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"R2-10-20241212","first-page":"119","article-title":"Co-administration of metformin and N-acetyl cysteine fails to improve clinical manifestations in PCOS individual undergoing ICSI","volume":"8","author":"Cheraghi","year":"2014","journal-title":"Int J Fertil Steril"},{"key":"R3-10-20241212","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1472-6483(10)60926-1","article-title":"Assisted reproduction in the treatment of polycystic ovarian syndrome","volume":"8","author":"Urman","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"R4-10-20241212","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1472-6483(10)61187-X","article-title":"Effect of oocyte morphology on embryo development and implantation","volume":"12","author":"Balaban","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"R6-10-20241212","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ydbio.2016.02.026","article-title":"ROCK inhibition abolishes the establishment of the aquiferous system in Ephydatia muelleri (Porifera, Demospongiae)","volume":"412","author":"Schenkelaars","year":"2016","journal-title":"Dev Biol"},{"key":"R7-10-20241212","first-page":"2120","article-title":"Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK\/PI3K\/JNK pathway","volume":"15","author":"Wu","year":"2018","journal-title":"Exp Ther Med"},{"key":"R8-10-20241212","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/jcm8030393","article-title":"Current progress in pharmacogenetics of second-line antidiabetic medications: towards precision medicine for type 2 diabetes","volume":"8","author":"Heo","year":"2019","journal-title":"J Clin Med"},{"key":"R9-10-20241212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.diabres.2012.05.022","article-title":"Effects of a combination of sitagliptin plus metformin vs. metformin monotherapy on glycemic control, \u03b2-cell function and insulin resistance in type 2 diabetic patients","volume":"98","author":"Derosa","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"R10-10-20241212","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/cen.13444","article-title":"Dipeptidyl peptidase 4 serum activity and concentration are increased in women with polycystic ovary syndrome","volume":"87","author":"Blauschmidt","year":"2017","journal-title":"Clin Endocrinol (Oxf"},{"key":"R11-10-20241212","first-page":"699","article-title":"Sitagliptin\/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus","volume":"37","author":"St. Onge","year":"2012","journal-title":"P T"},{"key":"R13-10-20241212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/dmp048","article-title":"World Health Organization reference values for human semen characteristics","volume":"16","author":"Cooper","year":"2010","journal-title":"Hum Reprod Update"},{"key":"R14-10-20241212","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4097\/kja.19049","article-title":"Randomization in clinical studies","volume":"72","author":"Lim","year":"2019","journal-title":"Korean J Anesthesiol"},{"key":"R15-10-20241212","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.tem.2020.09.002","article-title":"Sitagliptin\/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome","volume":"31","author":"Daneshjou","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"R16-10-20241212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/14767050600761893","article-title":"Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer","volume":"22","author":"Doldi","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"R17-10-20241212","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): A multicenter, double-blind, placebo-controlled randomized trial","volume":"97","author":"Morin-Papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-10-20241212","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1071\/RD14182","article-title":"N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: An alternative to metformin","volume":"28","author":"Cheraghi","year":"2016","journal-title":"Reprod Fertil Dev"},{"key":"R19-10-20241212","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertil Steril"},{"key":"R20-10-20241212","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/humrep\/der154","article-title":"Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: A prospective, randomized, double-blind, multi-centre study","volume":"26","author":"Kj\u00f8tr\u00f8d","year":"2011","journal-title":"Hum Reprod"},{"key":"R21-10-20241212","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/gye.17.3.207.214","article-title":"The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: An open-label randomized cross-over trial","volume":"17","author":"Fedorcs\u00e1k","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"R22-10-20241212","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/met.2017.0095","article-title":"Dipeptidyl peptidase-4 inhibitor sitagliptin prevented weight regain in obese women with polycystic ovary syndrome previously treated with liraglutide: A pilot randomized study","volume":"15","author":"Ferjan","year":"2017","journal-title":"Metab Syndr Relat Disord"},{"key":"R23-10-20241212","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1016\/j.fertnstert.2014.07.905","article-title":"Sitagliptin and metformin alone or in combination in patients with polycystic ovarian syndrome (PCOS): A pilot study","volume":"102","author":"Paredes-Palma","year":"2014","journal-title":"Fertil Steril"},{"key":"R24-10-20241212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.hgmx.2017.03.001","article-title":"Comparative treatment between sitagliptin vs. metformin, alone or in combination, in patients with polycystic ovary syndrome. A clinical entity at high risk for developing diabetes mellitus and gestational diabetes: A pilot study","volume":"81","author":"Palma","year":"2018","journal-title":"Rev M\u00e9d Hosp Gen M\u00e9xico"},{"key":"R25-10-20241212","first-page":"185","article-title":"Effects of metformin alone and in combination with sitagliptin on oxidative stress and proinflammatory markers in patients with diabetes mellitus type-2","volume":"42","author":"Al Hussona","year":"2017","journal-title":"Int J Pharm Sci Rev Res"},{"key":"R26-10-20241212","first-page":"1559","article-title":"Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling","volume":"15","author":"Tr\u00fcmper","year":"2001","journal-title":"Mol Endocrinol"},{"key":"R27-10-20241212","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jog.13847","article-title":"Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-\u03b21 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats","volume":"45","author":"Wang","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"R28-10-20241212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.peptides.2012.10.006","article-title":"The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK\/mTOR\/P70S6K signaling pathway","volume":"39","author":"Miao","year":"2013","journal-title":"Peptides"},{"key":"R29-10-20241212","first-page":"e22","article-title":"Sitagliptin suppresses apoptotic cell death and histological changes in the ovaries of rats with polycystic ovary syndrome","volume":"7","author":"Safaeian","year":"2021","journal-title":"Arch Med Lab Sci"},{"key":"R30-10-20241212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/EP-2017-0027","article-title":"DPP4 inhibitor sitagliptin as a potential treatment option in metformin-intolerant obese women with polycystic ovary syndrome: A pilot randomized study","volume":"24","author":"Ferjan","year":"2018","journal-title":"Endocr Pract"},{"key":"R31-10-20241212","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.fertnstert.2013.07.1689","article-title":"A novel therapy with sitagliptin for metformin-ineffective aged art repeaters: Increase in pregnancy rate by decreasing postprandial glycemic levels and advanced glycation endproducts","volume":"100","author":"Jinno","year":"2013","journal-title":"Fertil Steril"},{"key":"R32-10-20241212","doi-asserted-by":"crossref","first-page":"244","DOI":"10.22270\/jddt.v9i4-s.3261","article-title":"Sitagliptin recuperates oxidative stress and inflammatory cytokine expression in ovary of PCOS rats","volume":"9","author":"Carani","year":"2019","journal-title":"J Drug Deliv Ther"},{"key":"R33-10-20241212","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1463-1326.2011.01390.x","article-title":"The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus","volume":"13","author":"Reasner","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"R34-10-20241212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/11206060-000000000-00000","article-title":"Sitagliptin\/metformin fixed-dose combination: In patients with type 2 diabetes mellitus","volume":"71","author":"Chwieduk","year":"2011","journal-title":"Drugs"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_2139_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:06:08Z","timestamp":1751497568000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/comparative-evaluation-of-metformin-sitaformin-in-classic-pcos-patients-undergoing-intracytoplasmic-sperm-injection-a-randomized-controlled-pilot-study\/"}},"subtitle":["A randomized controlled pilot study"],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_2139_20","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}